Oct 7, 2026 08:00AM
Oct 5, 2026 08:00AM
Oct 1, 2026 08:00AM
Aug 11, 2026 08:00AM
Jul 29, 2026 08:00AM
Jul 27, 2026 08:00AM
Jul 21, 2026 08:02AM PharmaTher partners with KetaMist inventor to seek FDA approval
Jul 21, 2026 08:00AM
Jul 15, 2026 08:00AM
May 27, 2026 08:00AM
Apr 21, 2026 08:00AM
Apr 20, 2026 08:00AM
Apr 16, 2026 08:00AM
Mar 3, 2026 08:00AM PharmaTher Expands PharmaPatch Delivery Platform into Therapeutic Peptides for the U.S. Market
Feb 2, 2026 09:27AM
Jan 14, 2026 08:00AM
Jan 2, 2026 08:00AM
Dec 2, 2025 09:53AM
Nov 17, 2025 08:00AM
Oct 17, 2025 08:26AM
Oct 16, 2025 08:04AM PharmaTher prepares FDA package for ketamine Phase 3 Parkinson's study
Oct 16, 2025 08:00AM
Oct 15, 2025 08:00AM
Oct 8, 2025 08:00AM
Aug 27, 2025 08:00AM
Aug 14, 2025 08:02AM
Aug 14, 2025 08:00AM
Aug 11, 2025 09:51AM PharmaTher receives FDA approval for ketamine product KETARx
Aug 11, 2025 09:49AM
Aug 11, 2025 09:26AM
Aug 11, 2025 09:26AM
Jun 18, 2025 08:00AM
Mar 3, 2025 08:00AM
Sep 19, 2024 08:00AM
Aug 28, 2024 08:00AM PharmaDrug's Sairiyo Therapuetics Provides Strategic Plans to Advance PD-001 (Patented Reformulated Cepharanthine) for Viral Infectious Diseases
Aug 19, 2024 08:00AM
May 15, 2024 08:00AM
May 1, 2024 08:50AM
May 2, 2023 07:30AM
Apr 3, 2023 07:00AM
Mar 29, 2023 07:30AM
Feb 7, 2023 07:59AM PharmaTher Submits FDA Meeting Package to Discuss 505(b)(2) Pathway for New Drug Application of KETARX™ (Ketamine) On-Body Pump System
Feb 6, 2023 08:00AM
Feb 2, 2023 07:30AM
Feb 1, 2023 11:25AM
Jan 18, 2023 08:15AM
Jan 11, 2023 08:15AM
Dec 15, 2022 07:59AM
Nov 14, 2022 07:59AM PharmaTher Announces Poster Presentation of Positive Efficacy and Safety Data from Phase 1/2 Clinical Study of Ketamine in the Treatment of Levodopa-Induced Dyskinesia in Parkinson’s Disease at Neur
Nov 1, 2022 07:00AM

335,507 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All